AU2002221854A1 - Use of cetirizine or efletirizine for preventing urticaria - Google Patents

Use of cetirizine or efletirizine for preventing urticaria

Info

Publication number
AU2002221854A1
AU2002221854A1 AU2002221854A AU2185402A AU2002221854A1 AU 2002221854 A1 AU2002221854 A1 AU 2002221854A1 AU 2002221854 A AU2002221854 A AU 2002221854A AU 2185402 A AU2185402 A AU 2185402A AU 2002221854 A1 AU2002221854 A1 AU 2002221854A1
Authority
AU
Australia
Prior art keywords
efletirizine
cetirizine
urticaria
preventing
preventing urticaria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221854A
Inventor
Marc De Longueville
Luc Uylenbroeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Publication of AU2002221854A1 publication Critical patent/AU2002221854A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002221854A 2000-12-15 2001-11-15 Use of cetirizine or efletirizine for preventing urticaria Abandoned AU2002221854A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP00127600 2000-12-15
EP00127600.5 2000-12-15
EP01107022.4 2001-03-21
EP01107022 2001-03-21
PCT/EP2001/013232 WO2002047689A2 (en) 2000-12-15 2001-11-15 Use of cetirizine or efletirizine for preventing urticaria

Publications (1)

Publication Number Publication Date
AU2002221854A1 true AU2002221854A1 (en) 2002-06-24

Family

ID=26071671

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221854A Abandoned AU2002221854A1 (en) 2000-12-15 2001-11-15 Use of cetirizine or efletirizine for preventing urticaria

Country Status (2)

Country Link
AU (1) AU2002221854A1 (en)
WO (1) WO2002047689A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060484A1 (en) * 2004-07-14 2006-07-06 Ucb Farchim Sa LIQUID PHARMACEUTICAL PREPARATIONS CONTAINING A BENZHYDRIL PIPERIZINE COMPOUND
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0919550A1 (en) * 1997-11-26 1999-06-02 Ucb, S.A. Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
TW581675B (en) * 1998-08-18 2004-04-01 Ucb Sa A pharmaceutical composition for use in preventing the onset of asthma in a patient

Also Published As

Publication number Publication date
WO2002047689A3 (en) 2003-03-06
WO2002047689A2 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
AU2002336462A1 (en) Piperazine and homopiperazine compounds
GB0030710D0 (en) Piperazine derivatives
AU8395501A (en) Piperazine derivatives
IL148964A0 (en) Piperazine compounds
DZ3306A1 (en) Piperazine derivatives
AU2002352389A1 (en) Piperazine compounds and their phamaceutical use
AU2001292582A1 (en) C-nitroso compounds and use thereof
AU2001237041A1 (en) Kinase inhibitors
MXPA03002857A (en) Hydroxyesters of 7-desmethylrapamycin.
AU2001248748A1 (en) Substituted piperazine compounds
TW467382U (en) Embedded transformer
AU2002232468A1 (en) Pharmaceutical heterocyclic compounds
AU2001238590A1 (en) Substituted piperazine compounds
AU2002217071A1 (en) Novel use of polyhydroxy compounds
AU2000263864A1 (en) Tissue specific prodrug
AU2001258841A1 (en) Heterocyclic compounds
IL151178A0 (en) Substituted piperazine compounds
HUP0300560A3 (en) Formulation having mobilising activity
AU2002221854A1 (en) Use of cetirizine or efletirizine for preventing urticaria
AU4432001A (en) Trityl-type compounds and their use
AU2001276919A1 (en) Haplotypes of the mmp13 gene
ZA200109120B (en) Use of Arylalkanoylpyridazines.
HK1073243A1 (en) Use of N-(indolecarbonyl-) piperazine derivatives
AU2002221882A1 (en) Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors
AU2000272704A1 (en) Use of compounds for the treatment of obesity